Third European Medicines Agency (EMA) and Vaccines Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 25 November 2024
Agenda - Third EMA and Vaccines Europe bilateral meeting
Third Listen and Learn Focus Group (LLFG) meeting of the Quality Innovation Group (QIG), European Medicines Agency, Amsterdam, the Netherlands, from 4 June 2024 to 5 June 2024
Third listen-and-learn focus group meeting of the Quality Innovation Group, European Medicines Agency, Amsterdam, the Netherlands, from 4 June 2024 to 5 June 2024
Report - 3rd Listen and Learn Focus Group (LLFG) meeting of the Quality Innovation Group (QIG)
Human medicines European public assessment report (EPAR): Buccolam, midazolam, Date of authorisation: 04/09/2011, Revision: 21, Status: Authorised
ETF statement on the use of Imvanex for the prevention of mpox in children below 12 years of age
PSUSA/00001890/202401
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - February, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 February 2025 to 20 February 2025
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - May, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 May 2025 to 7 May 2025